公司资料

Ocugen 股价、新闻与催化剂

股票代码:: OCGN
交易所:: NASDAQ
行业:: Biopharma
所在地:: United States

股票表现

1.03 USD (+3.17%)

收盘价

最后更新: 2026年9月17日

454M USD

市值

股价为何变动

截至 2026年9月17日，OCGN 上涨 3.17%，收于 $1.03。当前新闻监测窗口内未发现新的同公司新闻。

公司概览

业务概览

Ocugen is a biotechnology company focused on ophthalmology, gene therapy, and vaccine-related programs. Its story has been shaped by a mix of platform ambition and strategic pivots.

所在地与行业分类

Headquartered in the United States and listed on NASDAQ, Ocugen sits in specialty biotechnology.

商业模式特征

The company depends on clinical development, partnership progress, and the ability to create value across a narrow set of programs.

生物医药行业定位

Ocugen is a high-uncertainty biotech name whose valuation is driven by strategy and development milestones.

未来催化剂

Ocugen’s catalysts are the gene-therapy and biologics pipeline, with any update on retinal or vaccine-related work shaping the next leg. The market will want a clearer human-data path before assigning more value.